DETECTION AND TREATMENT OF PROSTATE-CANCER - PERSPECTIVE OF THE UROLOGIST

被引:20
|
作者
OLSSON, CA
GOLUBOFF, ET
机构
关键词
PROSTATIC NEOPLASMS; ANTIGENS; NEOPLASM; DIAGNOSIS;
D O I
10.1016/S0022-5347(17)32364-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We examine changes in the detection and treatment of prostate cancer from the perspective of the urologist. There has been an extraordinary increase in the incidence of prostate cancer (60% from 1990 to 1993). We calculated, based on data from the literature and assumptions about changes in urological practice, that 52% of newly diagnosed cases would be treated by radical prostatectomy in 1993. Extrapolating from the work of Catalona, we derived the number of office consultations, prostate biopsies and orchiectomies associated with the diagnosis and treatment of these tumors. Applying Health Care Financing Administration reimbursements to our figures, we calculated that each urologist would realize $45,370 for prostate cancer care in the Medicare population in 1993. If all patients 50 to 70 years old were screened by American Cancer Society and American Urological Association recommended algorithms, this projection would be $107,919. Despite this enormous economic impact of prostate cancer on the urologist, uncertainties remain concerning the appropriateness of screening and treatment for this disease. Only increased funding for basic research in prostate cancer will resolve these uncertainties.
引用
收藏
页码:1695 / 1699
页数:5
相关论文
共 50 条
  • [41] IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN AS A PROGNOSTIC INDICATOR IN PROSTATE-CANCER
    SHURBAJI, MS
    KALBFLEISCH, JH
    THURMOND, TS
    HUMAN PATHOLOGY, 1995, 26 (01) : 106 - 109
  • [42] PROSTATE-CANCER, SCREENING AND THE GENERALIST PHYSICIAN
    ROBERTS, RG
    JOURNAL OF UROLOGY, 1994, 152 (05) : 1693 - 1694
  • [43] RISK-FACTORS FOR PROSTATE-CANCER
    PIENTA, KJ
    ESPER, PS
    ANNALS OF INTERNAL MEDICINE, 1993, 118 (10) : 793 - 803
  • [44] What risk of prostate cancer led urologist to recommend prostate biopsies?
    Roumiguie, M.
    Beauval, J. -B.
    Bordier, B.
    Filleron, T.
    Rozet, F.
    Ruffion, A.
    Mottet, N.
    Cussenot, O.
    Malavaud, B.
    PROGRES EN UROLOGIE, 2015, 25 (16): : 1125 - 1131
  • [45] Prostate Cancer Imaging What the Urologist Wants to Know
    Talab, Saman Shafaat
    Preston, Mark A.
    Elmi, Azadeh
    Tabatabaei, Shahin
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2012, 50 (06) : 1015 - +
  • [46] INDICATIONS FOR ULTRASOUND-GUIDED TRANSITION ZONE BIOPSIES IN THE DETECTION OF PROSTATE-CANCER
    LUI, PD
    TERRIS, MK
    MCNEAL, JE
    STAMEY, TA
    JOURNAL OF UROLOGY, 1995, 153 (03) : 1000 - 1003
  • [47] A WORSE PROGNOSIS FOR SMOKERS WITH PROSTATE-CANCER
    DANIELL, HW
    JOURNAL OF UROLOGY, 1995, 154 (01) : 153 - 157
  • [48] PROSTATE-CANCER - SCREENING, DIAGNOSIS, AND MANAGEMENT
    GARNICK, MB
    ANNALS OF INTERNAL MEDICINE, 1993, 118 (10) : 804 - 818
  • [49] PATHOLOGICAL FEATURES OF HEREDITARY PROSTATE-CANCER
    BASTACKY, SI
    WOJNO, KJ
    WALSH, PC
    CARMICHAEL, MJ
    EPSTEIN, JI
    JOURNAL OF UROLOGY, 1995, 153 (03) : 987 - 992
  • [50] THE USE OF PROSTATE-SPECIFIC ANTIGEN AND PROSTATE-SPECIFIC ANTIGEN DENSITY IN THE DIAGNOSIS OF PROSTATE-CANCER IN A COMMUNITY-BASED UROLOGY PRACTICE
    ROMMEL, FM
    AGUSTA, VE
    BRESLIN, JA
    HUFFNAGLE, HW
    POHL, CE
    SIEBER, PR
    STAHL, CA
    JOURNAL OF UROLOGY, 1994, 151 (01) : 88 - 93